EPIVX
Price
$13.91
Change
-$0.00 (-0.00%)
Updated
Nov 19 closing price
Net Assets
175.03M
VIHAX
Price
$41.34
Change
-$0.16 (-0.39%)
Updated
Nov 19 closing price
Net Assets
13.78B
Interact to see
Advertisement

EPIVX vs VIHAX

Header iconEPIVX vs VIHAX Comparison
Open Charts EPIVX vs VIHAXBanner chart's image
EuroPac International Value A
Price$13.91
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets175.03M
Vanguard Intl Hi Div Yld Adm
Price$41.34
Change-$0.16 (-0.39%)
VolumeN/A
Net Assets13.78B
EPIVX vs VIHAX Comparison Chart in %
View a ticker or compare two or three
VS
EPIVX vs. VIHAX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPIVX is a Hold and VIHAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIHAX has more cash in the bank: 13.8B vs. EPIVX (175M). VIHAX pays higher dividends than EPIVX: VIHAX (3.92) vs EPIVX (1.26). EPIVX was incepted earlier than VIHAX: EPIVX (16 years) vs VIHAX (10 years). EPIVX (1.73) is less costly to investors than VIHAX (0.17). EPIVX is a more actively managed with annual turnover of: 20.00 vs. VIHAX (11.00). EPIVX has a lower initial minimum investment than VIHAX: EPIVX (2500) vs VIHAX (3000). EPIVX annual gain was more profitable for investors over the last year : 31.22 vs. VIHAX (23.62). EPIVX return over 5 years is better than : 76.29 vs. VIHAX (56.15).
EPIVXVIHAXEPIVX / VIHAX
Total Expense Ratio1.730.171,018%
Annual Report Gross Expense Ratio1.730.171,018%
Fund Existence16 years10 years-
Gain YTD36.49027.338133%
Front Load5%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets175M13.8B1%
Annual Yield % from dividends1.263.9232%
Returns for 1 year31.2223.62132%
Returns for 3 years63.4150.32126%
Returns for 5 years76.2956.15136%
Returns for 10 years155.19N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LIMAX7.39N/A
N/A
Cromwell Tran Sustainable Focus Investor
AUICX35.52N/A
N/A
AB Equity Income C
ARIGX17.43N/A
N/A
Aristotle Growth Equity I
AUENX21.43-0.08
-0.37%
AQR Large Cap Defensive Style N
OAKLX83.37-0.32
-0.38%
Oakmark Select Investor